|
1
|
Oh J, Matkovich SJ, Riek AE, Bindom SM,
Shao JS, Head RD, Barve RA, Sands MS, Carmeliet G, Osei-Owusu P, et
al: Macrophage secretion of miR-106b-5p causes renin-dependent
hypertension. Nat Commun. 11(4798)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sun L, Zhang J and Li Y: Chronic central
miR-29b antagonism alleviates angiotensin II-induced hypertension
and vascular endothelial dysfunction. Life Sci.
253(116862)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lionakis N, Mendrinos D, Sanidas E,
Favatas G and Georgopoulou M: Hypertension in the elderly. World J
Cardiol. 4:135–147. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Romaine SPR, Charchar FJ, Samani NJ and
Tomaszewski M: Circulating microRNAs and hypertension-from new
insights into blood pressure regulation to biomarkers of
cardiovascular risk. Curr Opin Pharmacol. 27:1–7. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yin J, Liu H, Huan L, Song S, Han L, Ren
F, Zhang Z, Zang Z, Zhang J and Wang S: Role of miR-128 in
hypertension-induced myocardial injury. Exp Ther Med. 14:2751–2756.
2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Korea Centers for Disease Control and
Prevention: Korea Health Statistics 2021: Korea national health and
nutrition examination survey (KNHANES Ⅷ-3). Korea Centers for
Disease Control and Prevention, Chungcheongbuk-do, 2022. https://knhanes.kdca.go.kr/knhanes/sub04/sub04_04_01.do
(In Korean).
|
|
7
|
Aquino-Jarquin G: Emerging role of
CRISPR/Cas9 technology for microRNAs editing in cancer research.
Cancer Res. 77:6812–6817. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Cao Q, Lu K, Dai S, Hu Y and Fan W:
Clinicopathological and prognostic implications of the miR-200
family in patients with epithelial ovarian cancer. Int J Clin Exp
Pathol. 7:2392–2401. 2014.PubMed/NCBI
|
|
9
|
Zhao H, Guo Y, Sun Y, Zhang N and Wang X:
miR-181a/b-5p ameliorates inflammatory response in
monocrotaline-induced pulmonary arterial hypertension by targeting
endocan. J Cell Physiol. 235:4422–4433. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhang HG, Zhang QJ, Li BW, Li LH, Song XH,
Xiong CM, Zou YB, Liu BY, Han JQ and Xiu RJ: The circulating level
of miR-122 is a potential risk factor for endothelial dysfunction
in young patients with essential hypertension. Hypertens Res.
43:511–517. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Qian X, Zhao H and Feng Q: Invovlement of
miR-200b-PKCα signalling in pulmonary hypertension in cor
pulmonale model. Clin Exp Pharmacol Physiol. 4:478–484.
2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yang C, Zhang X, Yin H, Du Z and Yang Z:
MiR-429/200a/200b negatively regulate Notch1 signaling pathway to
suppress CoCl2-induced apoptosis in PC12 cells. Toxicol
In Vitro. 65(104787)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Saadat YR, Poursief MM, Vahed SZ,
Barzegari A, Omidi Y and Barar J: Modulatory role of
vaginal-isolated lactococcus lactis on the expression of miR-21,
miR-200b, and TLR-4 in CAOV-4 cells and in silico revalidation.
Probiotics Antimicrob Proteins. 12:1083–1096. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kim J, Choi GH, Ko KH, Kim JO, Oh SH, Park
YS, Kim OJ and Kim NK: Association of the single nucleotide
polymorphisms in mircoRNAs 130b, 200b, and 495 with ischemic stroke
susceptibility and post-stroke mortality. PLoS One.
11(e0162519)2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Opalinska JB, Bersenev A, Zhang Z,
Schmaier AA, Choi J, Yao Y, D'Souza J, Tong W and Weiss MJ:
MircoRNA expression in maturing murine megakaryocytes. Blood.
116:e128–e138. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Nagalla S, Shaw C, Kong K, Kondkar AA,
Edelstein LC, Ma L, Chen J, McKnight GS, López JA, Yang L, et al:
Platelet microRNA-mRNA coexpression profiles correlate with
platelet reactivity. Blood. 117:5189–5197. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
National Library of Medicine, National
Center for Biotechnology Information: dbSNP, Short genetic
variations. National Library of Medicine, Bethesda, MD, 2022.
http://www.ncbi.nlm.nih.gov/SNP.
|
|
18
|
Qin S, Shen C, Tang W, Wang M, Lin Y, Wang
Z, Li Y, Zhang Z and Liu X: Impact of miR-200b and miR-495 variants
on the risk of large-artery atherosclerosis stroke. Metab Brain
Dis. 38:631–639. 2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Choi GH, Ko KH, Kim JO, Kim J, Oh SH, Han
IB, Cho KG, Kim OJ, Bae J and Kim NK: Association of miR-34a,
miR-130a, miR-150 and miR-155 polymorphisms with the risk of
ischemic stroke. Int J Mol Med. 38:345–356. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kim EG, Kim JO, Park HS, Ryu CS, Oh J, Jun
HH, Kim JW and Kim NK: Genetic associations between the miRNA
polymorphisms miR-130b (rs373001), miR-200b (rs7549819), and
miR-495 (rs2281611) and colorectal cancer susceptibility. BMC
Cancer. 19(480)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Motawi TM, Sabry D, Maurice NW and Rizk
SM: Role of mesenchymal stem cells exosomes derived mircoRNAs;
miR-136. miR-494 and miR-495 in pre-eclampsia diagnosis and
evaluation. Arch Biochem Biophys. 659:13–21. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hu F, Tong J, Deng B, Zheng J and Lu C:
MiR-495 regulates macrophage M1/M2 polarization and insulin
resistance in high-fat diet-fed mice via targeting FTO. Pflugers
Arch. 471:1529–1537. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Fu J, Bai P, Chen W, Yu T and Li F:
Inhibition of miR-495 improves both vascular remodeling and
angiogenesis in pulmonary hypertension. J Vasc Res. 56:97–106.
2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Fu J, Chen Y and Li F: Attenuation of
microRNA-495 derepressed PTEN to effectively protect rat
cardiomyocytes from hypertrophy. Cardiology. 139:245–254.
2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wang G, Li X, Song L, Pan H, Jiang J and
Sun L: Long noncoding RNA MIAT promotes the progression of acute
myeloid leukemia by negatively regulating miR-495. Leuk Res.
87(106265)2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Boyle A, Kelly D, Zhang Y, Cox AJ, Gow RM,
Way K, Itescu S, Krum H and Gilbert RE: Inhibition of protein
kinase C reduces left ventricular fibrosis and dysfunction
following myocardial infarction. J Mol Cell Cardiol. 39:213–221.
2005.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Jin HF, Wang JF, Song TT, Zhang J and Wang
L: MiR-200b inhibits tumor growth and chemoresistance via targeting
p70S6K1 in lung cancer. Front Oncol. 10(643)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Piperigkou Z, Franchi M, Riethmüller C,
Götte M and Karamanos NK: miR-200b restrains EMT and aggressiveness
and regulates matrix composition depending on ER status and
signaling in mammary cancer. Matrix Biol Plus.
6-7(100024)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wu YT, Li JB, Lin HQ, Zhang GX, Hong CM,
Li M, Guo ZJ and Yang YB: Inhibition of miR-200b-3p alleviates
lipid accumulation and promotes cholesterol efflux by targeting
ABCA1 in macrophage-derived foam cells. Exp Ther Med.
22(831)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gatsiou A, Boeckel JN, Randriamboavonjy V
and Stellos K: MicroRNAs in platelet biogenesis and function:
Implication in vascular homeostasis and inflammation. Currt Vasc
Pharmacol. 10:524–531. 2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Gambaryan S, Kobsar A, Rukoyatkina N,
Herterich S, Geiger J, Smolenski A, Lohmann SM and Walter U:
Thrombin and collagen induce a feedback inhibitory signaling
pathway in platelets involving dissociation of the catalytic
subunit of protein kinase A from an NFκBNFkappaB-IkappaB complex. J
Biol Chem. 285:18352–18363. 2010.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Goode BL, Drubin DG and Barnes G:
Functional cooperation between the microtubule and actin
cytoskeletons. Curr Opin Cell Biol. 12:63–71. 2000.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Pedersen OB, Hvas AM, Grove EL, Larsen SB,
Pasalic L, Kristensen SD and Nissen PH: Association of whole blood
microRNA expression with platelet function and turnover in patients
with coronary artery disease. Thromb Res. 211:98–105.
2022.PubMed/NCBI View Article : Google Scholar
|
